Entheon Biomedical Corp. (ENTBF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 01:04PM EST
| Previous close | 0.0264 |
| Open | 0.0279 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0264 - 0.0264 |
| 52-week range | 0.0140 - 0.4320 |
| Volume | |
| Avg. volume | 20,552 |
| Market cap | 1.557M |
| Beta (5Y monthly) | 0.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1060 |
| Earnings date | 28 Oct 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research
AI-driven discovery platform enables new way to find novel pathways, as well as progress towards identifying patients who may better respond to drugs in the clinicGenetic test kit evaluates an individual's overall sensitivity and risk profile associated with psychedelic-assisted therapy MIAMI, June 01, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will begin using precision med
© 2022 Yahoo. All rights reserved.
